Dr. Osama A. Al-Bawab, MD

Dr. Al-Bawab practices at Euclid Hospital in Euclid, Ohio, part of The Cleveland Clinic Foundation.

Dr. Al-Bawab's NPI, 1609877075, was assigned on August 9, 2005. Dr. Al-Bawab graduated from Jordan University of Science and Technology FOM in 1991. Dr. Al-Bawab holds Ohio license 35.085801.

Dr. Al-Bawab's primary practice is Euclid Hospital, at 18901 Lake Shore Boulevard, Euclid, OH 44119 in Cuyahoga County. The practice phone is (216) 531-9000.

Dr. Al-Bawab's primary practice is Euclid Hospital in Euclid, Ohio, part of The Cleveland Clinic Foundation. Dr. Al-Bawab is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Al-Bawab to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Bawab practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Al-Bawab's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Al-Bawab is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Al-Bawab's licenses on file in 3 states: Ohio, Maine and Michigan.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Al-Bawab treats.

CMS data shows 939 Medicare services from Dr. Al-Bawab across 15 procedure codes in 2024, for 432 Medicare patients. Medicare paid $36,036 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 432 Medicare patients who saw Dr. Al-Bawab in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Bawab's median patient age at 67, with 52% women.

In 2024, Dr. Al-Bawab wrote 1,767 Medicare Part D claims for 278 patients. 77% of them were for generic drugs. CMS names the drug for 1,640 of them, across 29 drugs with 11 or more claims each, at $374,729 in total drug cost. In 2023, CMS named 1,219 claims across 21 drugs.

Dr. Al-Bawab accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 346 general payments to Dr. Al-Bawab from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $959.

Dmand AI lists 1 award for Dr. Al-Bawab, most recently CMS Stage 1 2012 in 2011.

Dr. Al-Bawab graduated from Jordan University of Science and Technology FOM in 1991.

Dr. Al-Bawab is in network with 20 carriers, including Aetna, Health Alliance Plan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.